Chapter 01 · The why
Why are brand-name GLP-1 medications so expensive?
GLP-1 medications are the most expensive class of weight-loss treatment retail pharmacies sell in 2026. GLP-1 (glucagon-like peptide-1) is a hormone the human body produces naturally; medications like semaglutide and tirzepatide are synthetic versions that help regulate appetite and slow gastric emptying so patients eat less and feel full longer.1 Most patients pay these prices out-of-pocket because most US insurance plans still treat obesity as a lifestyle issue rather than a medical condition.
The primary reason is patent protection. Novo Nordisk holds semaglutide patents through approximately 2031, and Eli Lilly holds tirzepatide patents through 2036, which gives each manufacturer single-source pricing power across the US market. With no generic competition allowed, the manufacturer sets the list price, the pharmacy adds margin, and the patient or insurer pays whatever lands at the counter.
US prices for GLP-1 medications run roughly ten times higher than in most peer nations with comparable safety standards.
Manufacturing complexity and R&D recoupment contribute as well, but the dominant factor is structural. A 2024 RAND analysis published with JAMA Internal Medicine found the same brand-name product at the same dose costs a fraction of the US price in Germany, Japan, or the United Kingdom.4
Chapter 02 · The difference
How is compounded medication different from the brand name?
Compounded semaglutide and tirzepatide are prepared by a licensed 503A compounding pharmacy under a physician's patient-specific prescription. A compounded medication is a distinct preparation; it is not FDA-approved and is not equivalent to the brand-name medications. The FDA recognizes 503A compounding as legal when a patient's clinical needs cannot be met by a commercially available product, or when shortage conditions apply.3 Individual results vary.
To be clear about who does what: sipra connects you with US-licensed physicians who decide whether compounded or branded medication is appropriate for you. We are not the compounder. The medication is dispensed by a registered 503A pharmacy partner, and your physician follows your case from prescription through every scheduled check-in.
| Medication | Brand-name retail | Compounded via sipra |
|---|---|---|
| Semaglutide (Wegovy®/Ozempic®) | $900 to $1,600/month | $79/mo |
| Tirzepatide (Mounjaro®/Zepbound®) | $1,000 to $1,300/month | $179/mo |
Sipra's price is fixed per molecule and does not change with dose. 6-month plan · $99/mo membership billed separately.
Chapter 03 · The fine print
What this estimate can and cannot tell you
This calculator estimates monthly savings based on average retail prices reported in May 2026. Your actual savings depend on your insurance, your pharmacy, your medication, your dose, and your physician's clinical judgment. Compounded GLP-1 medications are not FDA-approved for cosmetic weight loss.
The number above is a planning anchor, not a quote. Whether any option fits you is a clinical decision a licensed physician makes after reviewing your history.
$79 / mo$179 / mo*6-month plan · $99/mo membership billed separately.
